Clicky

IN8BIO INC. DL-0001(6JH) News

Date Title
Feb 14 IN8bio Presents Positive Phase 1 Data at TCT 2025, Highlighting Durability of Remissions in High-Risk AML
Feb 11 IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients